Co-targeting cancer drug escape pathways confers clinical advantage for multi-target anticancer drugs.
about
The antitumor effects of geraniol: Modulation of cancer hallmark pathways (Review)The Human Kinome Targeted by FDA Approved Multi-Target Drugs and Combination Products: A Comparative Study from the Drug-Target Interaction Network PerspectiveScreening and identification of Caulis Sinomenii bioactive ingredients with dual-target NF-κB inhibition and β2- AR agonizing activities.Therapeutic target database update 2016: enriched resource for bench to clinical drug target and targeted pathway information.Network-pharmacology-based validation of TAMS/CXCL-1 as key mediator of XIAOPI formula preventing breast cancer development and metastasis.Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics.Revealing vilazodone's binding mechanism underlying its partial agonism to the 5-HT1A receptor in the treatment of major depressive disorder.Determining the Balance Between Drug Efficacy and Safety by the Network and Biological System Profile of Its Therapeutic Target
P2860
Q28067149-B9253A8D-6FE0-4160-881D-669010961B0DQ28553277-A73EE93D-ECC6-48FE-8F09-FDE8680D6104Q36019984-5DA387B5-5BC7-4364-A172-39163605A4A9Q36434850-61507131-1C19-42BD-B032-87CC13DBF773Q47098338-DDF30189-74CB-4B44-BEB6-0FFE59F842F3Q47116549-984A4E7A-FC8C-4700-AB3D-99B111E3D9A0Q47732078-9D19EAA0-1B0E-48B7-B0B4-54D4CD5F798BQ59138094-909950C6-FD73-4D9D-BB82-F4294B76097E
P2860
Co-targeting cancer drug escape pathways confers clinical advantage for multi-target anticancer drugs.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Co-targeting cancer drug escap ...... multi-target anticancer drugs.
@en
type
label
Co-targeting cancer drug escap ...... multi-target anticancer drugs.
@en
prefLabel
Co-targeting cancer drug escap ...... multi-target anticancer drugs.
@en
P2093
P1476
Co-targeting cancer drug escap ...... multi-target anticancer drugs.
@en
P2093
P304
P356
10.1016/J.PHRS.2015.09.019
P577
2015-10-03T00:00:00Z